Your browser doesn't support javascript.
loading
Dynamic metrics-based biomarkers to predict responders to anti-PD-1 immunotherapy.
Liu, Can; He, Hua; Li, Xiaobing; Su, Maureen A; Cao, Yanguang.
Afiliación
  • Liu C; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
  • He H; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
  • Li X; School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, Jiangsu, China.
  • Su MA; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
  • Cao Y; Department of Pharmacy, Shengjing Hospital of China Medical University, 110004, Shenyang, Liaoning, China.
Br J Cancer ; 120(3): 346-355, 2019 02.
Article en En | MEDLINE | ID: mdl-30587849

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Melanoma Experimental / Interferón gamma / Receptor de Muerte Celular Programada 1 / Inmunoterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Melanoma Experimental / Interferón gamma / Receptor de Muerte Celular Programada 1 / Inmunoterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Br J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos